Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer [Phase 3]
A Phase 3 clinical trial evaluating whether adjunctive metformin reduces recurrence in non-diabetic patients with high-risk stage II or stag…
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection [Phase 2]
Phase 2 clinical trial evaluating Foeniculum vulgare (fennel) for gastrointestinal recovery after colorectal resection has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin [Phase 1, Phase 2]
A multi-modality imaging trial in colorectal-origin peritoneal carcinomatosis is described as Phase 1/Phase 2 with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer [Phase 1, Phase 2]
Phase I/II study evaluating an active immunotherapy using a cancer stem cell vaccine for colorectal cancer completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Mix Vaccine for Metastatic Colorectal Cancer [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/2 results for a mixed vaccine in metastatic colorectal cancer; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Phase II Study of Perindopril and Regorafenib in mCRC [Phase 2]
Phase II trial of perindopril in combination with regorafenib for metastatic colorectal cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2019-09-12Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating highly active natural killer cell immunotherapy for small metastases in metastatic colorectal cancer h…
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases [Phase 2]
Phase 2 trial evaluating Cetuximab/FOLFIRI with or without Oxaliplatin, and FOLFOXIRI with or without Bevacizumab for neoadjuvant treatment …
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment [Phase 3]
Phase 3 clinical trial update evaluating MGN1703 as maintenance treatment in metastatic colorectal cancer patients who showed tumor reductio…
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: New Individualized Therapy Trial for Metastatic Colorectal Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial of an individualized therapy for metastatic colorectal cancer has completed recruitment with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study) [Phase 2]
Phase 2 clinical trial update for first-line treatment of advanced colorectal cancer using RALOX or CAPOX plus Bevacizumab (ROCB study).
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Phase I/II Trial of Antagonism of HER in GI Cancer [Phase 2]
Phase II trial update on antagonism of HER in gastrointestinal cancer (metastatic/recurrent colorectal cancer) completed.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Study of Fruquintinib in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update for fruquintinib in metastatic colorectal cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients [NA]
This completed clinical trial evaluated strategies to increase colorectal cancer screening among Hispanic primary care patients; results wer…
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Lymphatic Mapping for Sentinel Node Identification and Analysis [Phase 2]
Phase 2 clinical trial on lymphatic mapping for sentinel node identification and analysis in colorectal cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the PillCam Colon 2 capsule endoscopy regimen for colonoscopy/colorectal examination.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial evaluated lower-dose or standard-dose regorafenib in patients with refractory metastatic colorectal cancer, with results pos…
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer [Phase 3]
Phase 3 trial investigating traditional Chinese medicine formula LC09 to treat hand-foot syndrome in patients receiving capecitabine for col…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients [Phase 1]
Phase 1 BEVZ92 bevacizumab biosimilar bioequivalence trial versus Avastin in first-line metastatic colorectal cancer completed with posted r…
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System [Phase 2]
Phase 2 trial evaluating an anti-HER2 therapy in HER2-positive metastatic cancers of the digestive system; status is not specified.
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating eFT508 alone and with avelumab in microsatellite stable colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas [Phase 1, Phase 2]
Phase I/II clinical trial update for SGM-101 in colon, rectal, and pancreatic cancers, currently completed.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer [Phase 1, Phase 2]
A clinical trial update investigating regorafenib in combination with XELOX as a second-line treatment for metastatic colorectal cancer (Pha…
-
FDA approval · 2019-06-27FDA Approved: ZIRABEV — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves ZIRABEV (bevacizumab-bvzr) from Pfizer as a biosimilar to Avastin under an Original Application. The approval covers multiple b…
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of capecitabine and oxaliplatin in advanced or metastatic colorectal cancer.